Self-monitoring of blood pressure following a stroke or transient ischaemic attack (TASMIN5S): a randomised controlled trial.
McManus RJ. et al, (2024), Bmc cardiovasc disord, 24
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial.
Sheppard JP. et al, (2024), Lancet healthy longev, 5, e563 - e573
Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
Sheppard J. et al, (2024), The lancet healthy longevity
Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial.
Kyle SD. et al, (2023), Lancet, 402, 975 - 987
OPTIMAL DRUGS FOR MEDICATION REDUCTION: SECONDARY ANALYSIS OF THE OPTIMISE MEDICATION REDUCTION TRIAL
Sheppard J. et al, (2021), Journal of hypertension, 39, E52 - E52
SHORT-TERM SAFETY OF ANTIHYPERTENSIVE MEDICATION REDUCTION IN MULTI-MORBID PATIENTS WITH MILD HYPERTENSION: THE OPTIMISE RANDOMISED CONTROLLED NON-INFERIORITY TRIAL
Sheppard J. et al, (2021), Journal of hypertension, 39, E369 - E370
Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients aged ≥ 80 years with hypertension
Sheppard J. et al, (2020), Jama: journal of the american medical association
A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial.
Pealing LM. et al, (2019), Pregnancy hypertens, 18, 141 - 149
Self-monitoring blood pressure in hypertensive pregnancies: the OPTIMUM-BP pilot randomised-controlled trial
Pealing L. et al, (2019), Bjog: an international journal of obstetrics and gynaecology, 126
Do these data apply to me? Examining the applicability of trials assessing strategies for optimal management of blood pressure to older patients in UK primary care
Sheppard J. et al, (2019), European heart journal, 40, 1604 - 1604
Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.
Khan K. et al, (2018), Gut, 67, 1484 - 1492